Evolve China PMCF Study
NCT: NCT06368622 · ACTIVE_NOT_RECRUITING
NCT IDNCT06368622
StatusACTIVE_NOT_RECRUITING
Start Date2024-04-24
Completion2031-08
Brief Summary
A prospective, multi-center, single-arm, open-label, observational, post-market clinical follow-up. The expected duration of the study is 8 years (including up to 5-years' follow-up). Each subject will be followed up per standard of care (SoC) at each study site.
Frequently Asked Questions
What is Evolve China PMCF Study?
Evolve China PMCF Study is a clinical trial registered under NCT06368622. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06368622?
The current status of NCT06368622 (Evolve China PMCF Study) is: ACTIVE_NOT_RECRUITING.
When did Evolve China PMCF Study start?
Evolve China PMCF Study started on 2024-04-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.